Eyeworld Daily News

2018 ASCRS Washington, D.C. Daily Wednesday-Ezine

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/989630

Contents of this Issue

Navigation

Page 5 of 51

Trust the industry-leading DuoVisc ® OVD system to deliver the powerful combination of: • Viscoat ® OVD with chondroitin sulfate for superior endothelial protection and retention 1-3 • ProVisc ® OVD for mechanical protection, space maintenance and clarity 4 Talk to your Alcon sales representative to learn how the DuoVisc ® OVD System can exceed your evolving needs. Your technologies and techniques have evolved. It's time to rethink your OVDs. © 2015 Novartis 6/15 VIS15002JAD Advancing CATARACT SURGERY DuoVisc ® VISCOELASTIC SYSTEM EXCEPTIONAL PERFORMANCE EVERY STEP OF THE WAY. 1-3 For important product information, please see adjacent page 1. Vasavada A, Ong M, Cordova D, Hartzer M. Protective eff ect ophthalmic viscosurgical devices (OVDs) against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: an in-vitro model. Presented at American Society of Cataract and Refractive Surgeons; April 3-8, 2009; San Francisco, CA. 2. Petroll WM, Jafari M, Lane SS, Jester JV, Cavanagh HD. Quantitative assessment of ophthalmic viscosurgical device retention using in vivo confocal microscopy. J Cataract Refract Surg. 2005;31(12):2363-2368. 3. Lindstrom RL, Ong M. Protective eff ect of OVDs against hydrogen peroxide-induced oxidative damage to corneal endothelial cells: in vitro model. Presented at ASCRS; 26 Mar 2011; San Diego, CA. 4. DuoVisc ® Package Insert.

Articles in this issue

Archives of this issue

view archives of Eyeworld Daily News - 2018 ASCRS Washington, D.C. Daily Wednesday-Ezine